Korean J Intern Med.  2010 Dec;25(4):364-371. 10.3904/kjim.2010.25.4.364.

Increased Expression of Cyclooxygenase-2 is Associated with the Progression to Cirrhosis

Affiliations
  • 1Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul, Korea. jyjang@hosp.sch.ac.kr
  • 2Department of Pathology, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.

Abstract

BACKGROUND/AIMS
To investigate the degree of cyclooxygenase-2 (COX-2) protein expression in chronic hepatitis and cirrhosis.
METHODS
COX-2 protein expression was evaluated in 43 cases of chronic hepatitis and 24 cases of cirrhosis using immunohistochemical techniques. The COX-2 immunohistochemical staining score was assessed using the scoring systems of Pazirandeh et al and Qiu et al. and each scoring system was based on a sum of the parameters of staining intensity and distribution.
RESULTS
The mean COX-2 expression scores in chronic hepatitis and cirrhosis were 2.5 +/- 1.3 vs. 3.3 +/- 1.1 (p = 0.008), and 3.2 +/- 2.0 vs. 4.5 +/- 1.7 (p = 0.006), respectively, based on the Pazirandeh et al. and Qiu et al. scoring systems. The percentage samples of high COX-2 expression score (4 to 5) in chronic hepatitis and cirrhosis were 16.3% vs. 45.8% (p = 0.022), and 23.3% vs. 50% (p = 0.021), respectively, based on the two scoring systems. The mean COX-2 expression scores based on the severity of hepatic fibrosis scored using Ishak's modified staging system (fibrosis score 0 to 3 vs. 4 to 6) were 2.4 +/- 1.3 vs. 3.2 +/- 1.1 (p = 0.009), and 3.1 +/- 2.0 vs. 4.3 +/- 1.8 (p = 0.009), respectively, based on the two scoring systems.
CONCLUSIONS
COX-2 expression was significantly higher in liver cirrhosis group than in chronic hepatitis. COX-2 expression scores according to Ishak's staging was significantly higher in the advanced fibrosis group. COX-2 may play a role in the progression of hepatic fibrosis.

Keyword

Cyclooxygenase 2; Immunohistochemistry; Hepatitis, chronic; Liver cirrhosis

MeSH Terms

Adult
Aged
Cyclooxygenase 2/analysis/*physiology
Cyclooxygenase 2 Inhibitors/therapeutic use
Disease Progression
Female
Hepatitis, Chronic/enzymology
Humans
Immunohistochemistry
Liver Cirrhosis/drug therapy/*enzymology
Male
Middle Aged
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr